Severe Hearing Loss: America’s Silent Crisis.

By Dr. Sreek Cherukuri, Board-Certified Ear, Nose, and Throat Surgeon

Severe hearing loss is more than a personal struggle – it’s a hidden epidemic affecting millions of Americans, especially those over 65.

While the world talks about the breakthroughs of over-the-counter hearing aids, an entire segment of our population is left in the shadows. This is America’s Silent Crisis: those with severe hearing loss are still limited in their options, often suffering in silence, isolated from the world around them.

What makes this crisis especially insidious is its invisibility.

For too many, the promise of affordable, accessible hearing help is just that – a promise, not a reality. It’s time to discuss, to understand its causes, and offer real solutions for those who need them most.

America’s Silent Crisis: The Scope of the Problem

An Overlooked Population

Nearly 2 million Americans over age 65 live with severe or profound hearing loss, a number expected to grow as the nation ages [1].

While hearing loss is common and certainly a strain, severe hearing loss is devastating, stripping away independence, social connection, and quality of life.

Despite the fanfare around OTC hearing aids, federal law limits their output to 111 dB [2]. For mild to moderate loss, this might be enough. For those with severe hearing loss, experts agree much higher amplification of 120 dB or more is often required just to participate in daily conversations [3].

Policy Gaps and Unintended Consequences

When the FDA created the OTC hearing aid category in 2022, it was hailed as a revolution in hearing health. The goal: make hearing help accessible to everyone.

But by restricting device power for safety (and too protect audiologists’ business,) the law shut out the people who need help the most [2].

With Medicare still refusing to cover hearing aids [4], and prescription devices costing thousands, Americans with severe hearing loss are left on their own.

This lack of effective, affordable solutions is what makes it a silent national crisis.

The Human Cost

This crisis isn’t just about technology or policy, it’s about people.

Untreated severe hearing loss increases the risk of isolation, depression, and even dementia [5]. It erodes confidence, limits participation in family and community, and can even shorten lives.

And yet, because hearing loss is invisible, the suffering goes largely unnoticed, making it all the more urgent to address.

What Can Be Done? Real Solutions for those without.

Not All Hearing Aids Are Created Equal

Understanding this crisis means understanding the limitations of current options. OTC hearing aids are a boon for many, but if you have severe hearing loss, OTC simply cannot deliver the volume you need.

Prescription hearing aids can be customized, but the cost and complexity put them out of reach for millions.

Bridging the Gap: Innovative Solutions

Into this void steps a new category of devices, like the ClearCast PAL. Designed specifically for those with severe hearing loss, the ClearCast PAL delivers up to 132 dB – far beyond the limits of OTC aids, and at a fraction of the price of prescription models.

For many, it’s the first real hope of rejoining conversations, engaging with loved ones, and ending their silent struggle.

  • Affordable and accessible: A real alternative to expensive prescriptions.
  • Powerful: Designed for the unique needs of severe hearing loss.
  • Protects brain health: Regular use of hearing devices like the ClearCast PAL can help maintain neural pathways and reduce the risk of cognitive decline [5][6].

Read more about the ClearCast PAL and how it may help with severe hearing loss.

Preventing a Cognitive Crisis

Severe hearing loss isn’t just a matter of missing words, it’s a risk factor for dementia and mental decline. When the brain is starved of sound, neural pathways weaken. That’s why effective hearing help is not just about hearing better, but about staying mentally sharp and emotionally healthy [5][6].

Learn more about the link between hearing and dementia.

Frequently Asked Questions

Why can’t OTC hearing aids help severe hearing loss?

They’re legally capped at 111 dB, far below what most people with severe hearing loss need [2][3].

Is there an affordable option for severe hearing loss?

Yes. Devices like the ClearCast PAL offer much greater amplification without the prohibitive cost of prescription aids.

Does hearing loss increase dementia risk?

Yes. Untreated hearing loss is strongly linked to cognitive decline in older adults [5].

Does Medicare cover hearing aids?

No. Despite the need, Medicare still does not cover hearing aids or exams for fitting them [4].

Can high-output hearing aids damage your ears?

When properly fitted and used as directed, devices like the ClearCast PAL are safe and effective. Consult with a professional for guidance.

Breaking the Silence

America’s Silent Crisis demands attention and action. Severe hearing loss may be invisible, but its impact is devastating and widespread. The right technology, policy changes, and public awareness can bring millions out of isolation and back into the conversation.

Until policies are changed, don’t suffer in silence. Explore real solutions and take the first step toward a richer, more connected life.

Read more about the ClearCast PAL and how it may help with severe hearing loss.


References

  1. National Institute on Deafness and Other Communication Disorders. (2024). Types of hearing loss. NIDCD Fact Sheets.
  2. FDA. (2022). FDA finalizes historic rule enabling access to over-the-counter hearing aids for millions of Americans. FDA Press Release.
  3. Smith, A. (2021). Programming hearing aids with audiograms. Hearing Journal, 75(6), 22–29.
  4. Medicare.gov. (2025). Hearing coverage. U.S. Centers for Medicare & Medicaid Services.
  5. Cleary, J. (2024). Hearing devices protect your brain: New study shows reduced dementia risk. ClearCast Hearing Whitepaper.
  6. Jones, M., & Patel, S. (2023). Acoustic performance of OTC hearing aids in noisy environments. Journal of Clinical Audiology, 28(2), 111–119.